- Multiplex assays are advanced diagnostic tools that enable the simultaneous detection and quantification of multiple analytes in a single sample, making them essential for applications in drug discovery, biomarker validation, and disease diagnostics
- The demand for multiplex assays is significantly driven by the increasing prevalence of chronic and infectious diseases, advancements in proteomics and genomics, and the growing need for high-throughput screening in pharmaceutical research
- North America is expected to dominate the multiplex assays market with 42.6% market share, due to its well-established healthcare infrastructure, high R&D investments, and the presence of leading biotechnology and pharmaceutical companies
- Asia-Pacific is expected to be the fastest growing region in the multiplex assays market with 30.8% market share during the forecast period, driven by increasing healthcare spending, growing awareness of advanced diagnostic techniques, and the rising prevalence of chronic diseases
- Protein multiplex assays segment is expected to dominate the market with a market share of 53.3% in 2025 due to its critical role in biomarker research and clinical diagnostics. As a leading technology for simultaneous detection and quantification of multiple protein biomarkers, protein multiplex assays significantly enhance diagnostic efficiency and drug development processes
